{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:38:41Z","timestamp":1792057121293,"version":"4.4.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T00:00:00Z","timestamp":1574208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T00:00:00Z","timestamp":1574208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA016672"],"award-info":[{"award-number":["P30CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["U01CA216468"],"award-info":[{"award-number":["U01CA216468"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Recent reports have shown that very high dose rate radiation (35\u2013100\u2009Gy\/second) referred to as FLASH tends to spare the normal tissues while retaining the therapeutic effect on tumor. We undertook a series of experiments to assess if ultra-high dose rate of 35\u2009Gy\/second can spare the immune system in models of radiation induced lymphopenia. We compared the tumoricidal potency of ultra-high dose rate and conventional dose rate radiation using a classical clonogenic assay in murine pancreatic cancer cell lines. We also assessed the lymphocyte sparing potential in cardiac and splenic irradiation models of lymphopenia and assessed the severity of radiation-induced gastrointestinal toxicity triggered by the two dose rate regimes\n                    <jats:italic>in vivo<\/jats:italic>\n                    . Ultra-high dose rate irradiation more potently induces clonogenic cell death than conventional dose rate irradiation with a dose enhancement factor at 10% survival (DEF\n                    <jats:sub>10<\/jats:sub>\n                    ) of 1.310 and 1.365 for KPC and Panc02 cell lines, respectively. Ultra-high dose rate was equally potent in depleting CD3, CD4, CD8, and CD19 lymphocyte populations in both cardiac and splenic irradiation models of lymphopenia. Radiation-induced gastrointestinal toxicity was more pronounced and mouse survival (7 days\n                    <jats:italic>vs<\/jats:italic>\n                    . 15 days,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0001) was inferior in the ultra-high dose rate arm compared to conventional dose rate arm. These results suggest that, contrary to published data in other models of radiation-induced acute and chronic toxicity, dose rates of 35\u2009Gy\/s do not protect mice from the detrimental side effects of irradiation in our models of cardiac and splenic radiation-induced lymphopenia or gastrointestinal mucosal injury.\n                  <\/jats:p>","DOI":"10.1038\/s41598-019-53562-y","type":"journal-article","created":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T06:04:02Z","timestamp":1574229842000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":131,"title":["Ultra high dose rate (35\u2009Gy\/sec) radiation does not spare the normal tissue in cardiac and splenic models of lymphopenia and gastrointestinal syndrome"],"prefix":"10.1038","volume":"9","author":[{"given":"Bhanu Prasad","family":"Venkatesulu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrish","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julianne M.","family":"Pollard-Larkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramaswamy","family":"Sadagopan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2719-6309","authenticated-orcid":false,"given":"Jessica","family":"Symons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Neri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Tailor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven H.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,20]]},"reference":[{"key":"53562_CR1","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/cncr.21324","volume":"104","author":"G Delaney","year":"2005","unstructured":"Delaney, G., Jacob, S., Featherstone, C. & Barton, M. The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer 104, 1129\u20131137 (2005).","journal-title":"Cancer"},{"key":"53562_CR2","doi-asserted-by":"publisher","first-page":"245ra293","DOI":"10.1126\/scitranslmed.3008973","volume":"6","author":"V Favaudon","year":"2014","unstructured":"Favaudon, V. et al. Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice. Sci Transl Med 6, 245ra293 (2014).","journal-title":"Sci Transl Med"},{"key":"53562_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1158\/1078-0432.CCR-17-3375","volume":"25","author":"MC Vozenin","year":"2019","unstructured":"Vozenin, M. C. et al. The Advantage of FLASH Radiotherapy Confirmed in Mini-pig and Cat-cancer Patients. Clin Cancer Res 25, 35\u201342 (2019).","journal-title":"Clin Cancer Res"},{"key":"53562_CR4","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.radonc.2017.05.003","volume":"124","author":"P Montay-Gruel","year":"2017","unstructured":"Montay-Gruel, P. et al. Irradiation in a flash: Unique sparing of memory in mice after whole brain irradiation with dose rates above 100\u2009Gy\/s. Radiother Oncol 124, 365\u2013369 (2017).","journal-title":"Radiother Oncol"},{"key":"53562_CR5","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.radonc.2018.08.016","volume":"129","author":"P Montay-Gruel","year":"2018","unstructured":"Montay-Gruel, P. et al. X-rays can trigger the FLASH effect: Ultra-high dose-rate synchrotron light source prevents normal brain injury after whole brain irradiation in mice. Radiother Oncol 129, 582\u2013588 (2018).","journal-title":"Radiother Oncol"},{"key":"53562_CR6","doi-asserted-by":"publisher","first-page":"838","DOI":"10.3109\/0284186X.2011.582513","volume":"50","author":"JM Schippers","year":"2011","unstructured":"Schippers, J. M. & Lomax, A. J. Emerging technologies in proton therapy. Acta Oncol 50, 838\u2013850 (2011).","journal-title":"Acta Oncol"},{"key":"53562_CR7","doi-asserted-by":"publisher","first-page":"5376","DOI":"10.1118\/1.3490086","volume":"37","author":"T Matsuura","year":"2010","unstructured":"Matsuura, T. et al. Apparent absence of a proton beam dose rate effect and possible differences in RBE between Bragg peak and plateau. Med Phys 37, 5376\u20135381 (2010).","journal-title":"Med Phys"},{"key":"53562_CR8","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1158\/1078-0432.CCR-11-0774","volume":"17","author":"SA Grossman","year":"2011","unstructured":"Grossman, S. A. et al. Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide. Clin Cancer Res 17, 5473\u20135480 (2011).","journal-title":"Clin Cancer Res"},{"key":"53562_CR9","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.radonc.2015.10.029","volume":"118","author":"H Moon","year":"2016","unstructured":"Moon, H. et al. Prognostic value of nutritional and hematologic markers in head and neck squamous cell carcinoma treated by chemoradiotherapy. Radiother Oncol 118, 330\u2013334 (2016).","journal-title":"Radiother Oncol"},{"key":"53562_CR10","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ijrobp.2016.10.046","volume":"97","author":"AS Chadha","year":"2017","unstructured":"Chadha, A. S. et al. Does Unintentional Splenic Radiation Predict Outcomes After Pancreatic Cancer Radiation Therapy? Int J Radiat Oncol Biol Phys 97, 323\u2013332 (2017).","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"53562_CR11","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.ijrobp.2014.04.025","volume":"89","author":"C Tang","year":"2014","unstructured":"Tang, C. et al. Lymphopenia association with gross tumor volume and lung V5 and its effects on non-small cell lung cancer patient outcomes. Int J Radiat Oncol Biol Phys 89, 1084\u20131091 (2014).","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"53562_CR12","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.ijrobp.2010.10.042","volume":"82","author":"BI Carr","year":"2012","unstructured":"Carr, B. I. & Metes, D. M. Peripheral blood lymphocyte depletion after hepatic arterial 90Yttrium microsphere therapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 82, 1179\u20131184 (2012).","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"53562_CR13","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ijrobp.2017.05.037","volume":"99","author":"R Davuluri","year":"2017","unstructured":"Davuluri, R. et al. Lymphocyte Nadir and Esophageal Cancer Survival Outcomes After Chemoradiation Therapy. Int J Radiat Oncol Biol Phys 99, 128\u2013135 (2017).","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"53562_CR14","first-page":"3541","volume":"36","author":"O Cho","year":"2016","unstructured":"Cho, O., Chun, M., Chang, S. J., Oh, Y. T. & Noh, O. K. Prognostic Value of Severe Lymphopenia During Pelvic Concurrent Chemoradiotherapy in Cervical Cancer. Anticancer Res 36, 3541\u20133547 (2016).","journal-title":"Anticancer Res"},{"key":"53562_CR15","first-page":"840","volume":"39","author":"C O\u2019Toole","year":"1979","unstructured":"O\u2019Toole, C. & Unsgaard, B. Clinical status and rate of recovery of blood lymphocyte levels after radiotherapy for bladder cancer. Cancer Res 39, 840\u2013843 (1979).","journal-title":"Cancer Res"},{"key":"53562_CR16","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ijrobp.2018.09.010","volume":"103","author":"LRG Pike","year":"2019","unstructured":"Pike, L. R. G. et al. The Impact of Radiation Therapy on Lymphocyte Count and Survival in Metastatic Cancer Patients Receiving PD-1 Immune Checkpoint Inhibitors. Int J Radiat Oncol Biol Phys 103, 142\u2013151 (2019).","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"53562_CR17","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.radonc.2017.11.028","volume":"128","author":"Y Shiraishi","year":"2018","unstructured":"Shiraishi, Y. et al. Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: A propensity matched analysis of the relative risk of proton versus photon-based radiation therapy. Radiother Oncol 128, 154\u2013160 (2018).","journal-title":"Radiother Oncol"},{"key":"53562_CR18","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.21873\/invivo.11409","volume":"32","author":"T Saito","year":"2018","unstructured":"Saito, T. et al. Spleen Dose-Volume Parameters as a Predictor of Treatment-related Lymphopenia During Definitive Chemoradiotherapy for Esophageal Cancer. In Vivo 32, 1519\u20131525 (2018).","journal-title":"In Vivo"},{"key":"53562_CR19","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.radonc.2018.02.025","volume":"128","author":"P Fang","year":"2018","unstructured":"Fang, P. et al. High lymphocyte count during neoadjuvant chemoradiotherapy is associated with improved pathologic complete response in esophageal cancer. Radiother Oncol 128, 584\u2013590 (2018).","journal-title":"Radiother Oncol"},{"key":"53562_CR20","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3109\/07357907.2012.700987","volume":"30","author":"A Balmanoukian","year":"2012","unstructured":"Balmanoukian, A., Ye, X., Herman, J., Laheru, D. & Grossman, S. A. The association between treatment-related lymphopenia and survival in newly diagnosed patients with resected adenocarcinoma of the pancreas. Cancer Invest 30, 571\u2013576 (2012).","journal-title":"Cancer Invest"},{"key":"53562_CR21","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/COC.0b013e3182940ff9","volume":"38","author":"AT Wild","year":"2015","unstructured":"Wild, A. T. et al. The Association Between Chemoradiation-related Lymphopenia and Clinical Outcomes in Patients With Locally Advanced Pancreatic Adenocarcinoma. Am J Clin Oncol 38, 259\u2013265 (2015).","journal-title":"Am J Clin Oncol"},{"key":"53562_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-017-0824-x","volume":"12","author":"J Liu","year":"2017","unstructured":"Liu, J. et al. Radiation-related lymphopenia is associated with spleen irradiation dose during radiotherapy in patients with hepatocellular carcinoma. Radiat Oncol 12, 90 (2017).","journal-title":"Radiat Oncol"},{"key":"53562_CR23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ctro.2018.01.004","volume":"9","author":"J Miszczyk","year":"2018","unstructured":"Miszczyk, J. et al. Do protons and X-rays induce cell-killing in human peripheral blood lymphocytes by different mechanisms? Clin Transl Radiat Oncol 9, 23\u201329 (2018).","journal-title":"Clin Transl Radiat Oncol"},{"key":"53562_CR24","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.critrevonc.2018.01.003","volume":"123","author":"BP Venkatesulu","year":"2018","unstructured":"Venkatesulu, B. P., Mallick, S., Lin, S. H. & Krishnan, S. A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors. Crit Rev Oncol Hematol 123, 42\u201351 (2018).","journal-title":"Crit Rev Oncol Hematol"},{"key":"53562_CR25","doi-asserted-by":"crossref","unstructured":"Chang, D. S., Lasley, F. D., Das, I. J., Mendonca, M. S. & Dynlacht, J. R. In Basic Radiotherapy Physics and Biology (eds David S. Chang et al.) 265\u2013275 (Springer International Publishing, 2014).","DOI":"10.1007\/978-3-319-06841-1_26"},{"key":"53562_CR26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ijrobp.2016.09.018","volume":"97","author":"E Schuler","year":"2017","unstructured":"Schuler, E. et al. Experimental Platform for Ultra-high Dose Rate FLASH Irradiation of Small Animals Using a Clinical Linear Accelerator. Int J Radiat Oncol Biol Phys 97, 195\u2013203 (2017).","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"53562_CR27","doi-asserted-by":"publisher","first-page":"E16","DOI":"10.1016\/j.ijrobp.2017.02.101","volume":"98","author":"BW Loo","year":"2017","unstructured":"Loo, B. W. et al. (P003) Delivery of Ultra-Rapid Flash Radiation Therapy and Demonstration of Normal Tissue Sparing After Abdominal Irradiation of Mice. Int J Radiat Oncol Biol Phys 98, E16 (2017).","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"53562_CR28","doi-asserted-by":"crossref","unstructured":"Kim, H. J., Hong, B.-J., Shueler, E., Loo, B. W. Jr. & Ahn, G.-O. PV-0572 Biological effects by the next generation of ultra-fast dose rate ionizing radiation \u2018FLASH\u2019 (2017).","DOI":"10.1016\/S0167-8140(18)30882-X"},{"key":"53562_CR29","doi-asserted-by":"crossref","unstructured":"Beyreuther, E. et al. Feasibility of proton FLASH effect tested by zebrafish embryo irradiation. Radiother Oncol (2019).","DOI":"10.1016\/j.radonc.2019.06.024"},{"key":"53562_CR30","doi-asserted-by":"crossref","unstructured":"Buonanno, M., Grilj, V. & Brenner, D. J. Biological effects in normal cells exposed to FLASH dose rate protons. Radiother Oncol (2019).","DOI":"10.1016\/j.radonc.2019.02.009"},{"key":"53562_CR31","doi-asserted-by":"crossref","unstructured":"Bourhis, J. et al. Treatment of a first patient with FLASH-radiotherapy. Radiother Oncol (2019).","DOI":"10.1016\/j.radonc.2019.06.019"},{"key":"53562_CR32","doi-asserted-by":"publisher","first-page":"10943","DOI":"10.1073\/pnas.1901777116","volume":"116","author":"P Montay-Gruel","year":"2019","unstructured":"Montay-Gruel, P. et al. Long-term neurocognitive benefits of FLASH radiotherapy driven by reduced reactive oxygen species. Proc Natl Acad Sci USA 116, 10943\u201310951 (2019).","journal-title":"Proc Natl Acad Sci USA"},{"key":"53562_CR33","doi-asserted-by":"crossref","unstructured":"Simmons, D. A. et al. Reduced cognitive deficits after FLASH irradiation of whole mouse brain are associated with less hippocampal dendritic spine loss and neuroinflammation. Radiother Oncol (2019).","DOI":"10.1016\/j.radonc.2019.06.006"}],"updated-by":[{"DOI":"10.1038\/s41598-020-67913-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T00:00:00Z","timestamp":1593475200000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53562-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53562-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53562-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T11:08:34Z","timestamp":1671275314000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53562-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,20]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["53562"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-53562-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,20]]},"assertion":[{"value":"8 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An amendment to this paper has been published and can be accessed via a link at the top of the paper.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17180"}}